Royal Biologics Announces the Launch of Cryo-Cord™, the First Non-DMSO Viable Umbilical Cord Graft

NEXT STORY
Global Immunoassay Markets to 2025 – Growing Adoption of Immunoassay-based POC Diagnostics
PREV STORY
Next-generation Sequencing (NGS) Market Outlook, 2020-2025 – Drug Discovery Applications Demanding NGS Technology Spur Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bars And Cafes Global Market Report 2022

author_avatar
NASDAQ Market News

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

SAN ANTONIO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today ...

author_avatar
NASDAQ Market News

MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology

author_avatar
NASDAQ Market News